CPO and hepatocellular carcinoma: Our results showed that CPO decreased CD133 expression; thus, we analyzed the effects of CPO-induced CD133 degradation on genome-wide alterations in gene expression in HCC using RNA-seq, an influential approach for investigating drug-induced changes in genome-wide gene expression.